Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States | Zendy

William C. Goedel | Zendy; Aaron Shapiro | Zendy; Magdalena Cerdá | Zendy; Jennifer Tsai | Zendy; Scott E. Hadland | Zendy; Brandon D. L. Marshall | Zendy

Open Access

Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States

Author(s) -

William C. Goedel,

Aaron Shapiro,

Magdalena Cerdá,

Jennifer Tsai,

Scott E. Hadland,

Brandon D. L. Marshall

Publication year - 2020

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2020.3711

Subject(s) - buprenorphine , ethnic group , opioid use disorder , methadone , population , census , demography , substance abuse , medicine , gerontology , psychiatry , environmental health , opioid , political science , sociology , receptor , law

Key Points Question Does county-level capacity to provide methadone and buprenorphine vary with measures of racial/ethnic segregation? Findings In this cross-sectional study of all 3142 counties or county-equivalent units in the US in 2016, counties with highly segregated African American and Hispanic/Latino communities had more facilities to provide methadone per capita, while counties with highly segregated white communities had more facilities to provide buprenorphine per capita. Meaning These findings suggest that policy reforms are warranted to ensure equal access to both methadone and buprenorphine among all patients with opioid use disorder.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research